2018
DOI: 10.1016/j.ijantimicag.2018.05.010
|View full text |Cite
|
Sign up to set email alerts
|

The GISA call to action for the appropriate use of antimicrobials and the control of antimicrobial resistance in Italy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 23 publications
(13 citation statements)
references
References 38 publications
0
13
0
Order By: Relevance
“…Laboratory-based surveillance of MDROs should be associated to a careful infection monitoring -e.g. of incidence of urinary tract infections or central line associated bacteremia-, by healthcare providers within the LTCF, and should also be paralleled by evaluation of the consumption of antibiotics in the institution, as key prerequisites for the implementation of an infection control and antimicrobial stewardship programs [22,23]. In any case, routine environmental cultures or samples from asymptomatic personnel are not recommended, except as target for an epidemiologic investigation.…”
Section: Surveillance Recommendations For Mdros In Italian Ltcfsmentioning
confidence: 99%
“…Laboratory-based surveillance of MDROs should be associated to a careful infection monitoring -e.g. of incidence of urinary tract infections or central line associated bacteremia-, by healthcare providers within the LTCF, and should also be paralleled by evaluation of the consumption of antibiotics in the institution, as key prerequisites for the implementation of an infection control and antimicrobial stewardship programs [22,23]. In any case, routine environmental cultures or samples from asymptomatic personnel are not recommended, except as target for an epidemiologic investigation.…”
Section: Surveillance Recommendations For Mdros In Italian Ltcfsmentioning
confidence: 99%
“…19 Above all, the hypothesis is not supported by the findings of AMR country visits carried out by the ECDC in recent years within high-prescribing EU/EEA countries. 20 A study of this specific focus will invariably have some limitations. Other factors not included in the model, such as population, geographic distribution, pharmaceutical availabilities and healthcare structures, could be relevant drivers of Br-Ab prescribing behaviour.…”
Section: Masculinity (Mas)mentioning
confidence: 99%
“…It has particular importance since reducing the spread of MDRO represents one of the priorities worldwide [100]. New mechanisms of resistance are continuously emerging, leading to delayed diagnosis and worse patient outcome [101]. This paper has the following goals:…”
Section: Expert Opinionmentioning
confidence: 99%